Details
Product Name in the RMS: Pantoprazol Aurobindo 40 mg gastro-resistant tablets
MR Number: NL/H/2944/002
Date of outcome: 17.06.2014
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
pantoprazole sesquihydrate 40 mg |
Form | Gastro-resistant tablet |
MA Holder in the RMS |
Aurobindo Pharma BV Molenvliet 103 3335 LH Zwijndrecht The Netherlands |
RMS | Netherlands |
Date of last change | 18.12.2020 |
ATC-Code |
A02BC02 Pantoprazole |
CMS Country | Domestic Product Name |
---|---|
Cyprus | PANTOPRAZOLE AUROBINDO GR TABS |
Denmark | |
France | |
Germany | Pantoprazol Aurobindo 40 mg magensaftresistente Tablette |
Italy | |
Malta | Pantoprazole Aurobindo 40 mg gastro-resistant tablets |
Poland | |
Romania | Pantoprazol Aurobindo 40 mg comprimate gastrorezistente |
Spain | |
Sweden | |
United Kingdom |
Documents | |
---|---|
PAR: | NL_H_2944_002_PAR.pdf (08.12.2014) |
PARSummary: | NL_H_2944_002_PARSummary.pdf (08.12.2014) |
FinalSPC: | NL_H_2944_002_FinalSPC.pdf (08.10.2020) |
FinalPL: | NL_H_2944_002_FinalPL.pdf (08.10.2020) |
FinalLabelling: | NL_H_2944_002_FinalLabelling_1of2.pdf (26.03.2019) |
FinalLabelling: | NL_H_2944_002_FinalLabelling_2of2.pdf (26.03.2019) |
Finalised Product Information: | NL_H_2944_002_FinalPI_1of6.pdf (09.07.2015) |
Finalised Product Information: | NL_H_2944_002_FinalPI_2of6.pdf (09.07.2015) |
Finalised Product Information: | NL_H_2944_002_FinalPI_3of6.pdf (09.07.2015) |
Finalised Product Information: | NL_H_2944_002_FinalPI_4of6.pdf (09.07.2015) |
Finalised Product Information: | NL_H_2944_002_FinalPI_5of6.pdf (09.07.2015) |
Finalised Product Information: | NL_H_2944_002_FinalPI_6of6.pdf (09.07.2015) |